Dr. Kubek is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2525 W University Avenue
Suite 403
Muncie, IN 47304Phone+1 765-751-1700
Education & Training
- Carolinas Medical CenterFellowship, Craniofacial Surgery and Pediatric Plastic Surgery, 2015
- University of Colorado School of MedicineResidency, Plastic Surgery - Integrated, 2012 - 2015
- Carolinas Medical CenterResidency, Surgery, 2008 - 2012
- Western Michigan University Homer Stryker MD School of MedicineInternship, Transitional Year, 2007 - 2008
- Michigan State University College of Human MedicineClass of 2007
Certifications & Licensure
- IN State Medical License 2017 - 2025
- NC State Medical License 2008 - 2018
- NE State Medical License 2016 - 2018
- CO State Medical License 2012 - 2017
- MI State Medical License 2007 - 2008
- American Board of Plastic Surgery Plastic Surgery
- American Board of Surgery Surgery
Publications & Presentations
PubMed
- Nonpersistence of basal cell carcinoma after diagnostic shave biopsy: reconstruction when specimen is negative during surgery.Raffi Gurunluoglu, Eddie Kubek, Jamie Arton, Adam Olsen, Michael Bronsert
Annals of Plastic Surgery. 2015-06-01 - 4 citationsNo Residual Basal Cell Carcinoma after Excision for Biopsy-proven Tumor: Clinical and Medicolegal ImplicationsRaffi Gurunluoglu, Eddie Kubek, Jamie Arton, Adam Olsen, Michael Bronsert
Plastic and Reconstructive Surgery. Global Open. 2013-12-01 - 12 citationsDual Pedicle Mastopexy Technique for Reorientation of Volume and Shape After Subglandular and Submuscular Breast Implant RemovalRaffi Gurunluoglu, Edward W. Kubek, Jamie Arton
Eplasty. 2013-09-16
Journal Articles
- Dual pedicle mastopexy technique for reorientation of volume and shape after subglandular and submuscular breast implant removalGurunluoglu, R, Kubek E, Arton J, Eplasty, 9/16/2013
Books/Book Chapters
Research History
- Founder and Chief Medical Officer, ChemoKind IncChemoKind's proprietary therapeutic platforms make possible the removal of disease causing organisms/cells by way of directed chemotaxis. Using this strategy, offending cells are removed, not killed, thus, instead of developing resistance, organisms become more sensitive to therapy over time.2015 - Present
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: